Hangzhou Huasai Biomedicine Co., Ltd.
Hangzhou Huasai Biomedicine Co., Ltd.
Explore linked clinical trials.9 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study of HS-IT101 Injection in Patients With Advanced Non-Small Cell Lung Cancer | Advanced NSCLC | Recruiting | Phase 1 | 2026-09-29 | NCT07830342 | |
| Clinical Study of HS-IT101 Injection in the Treatment of Advanced Renal Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, clear cell renal carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorder | Recruiting | Phase 1 | 2026-09-29 | NCT07770802 | |
| HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Not yet recruiting | Phase 2 | 2026-02-12 | NCT07406724 | |
| HS-IT101 Injection for Advanced NSCLC | Advanced Non-Small Cell Lung Cancer | Not yet recruiting | Phase 1 | 2025-08-19 | NCT07105176 | |
| HS-IT101 Injection in the Treatment of Advanced Melanoma | Advanced Melanoma | Enrolling by invitation | Phase 1 | 2025-08-14 | NCT06941818 | |
| HS-IT201 Injection in the Treatment of Advanced Solid Tumors | Solid Tumor | Not yet recruiting | Early phase 1 | 2024-09-25 | NCT06613152 | |
| HS-IT101 Injection in the Treatment of Advanced Solid Tumors | Solid Tumor | Recruiting | Phase 1 | 2024-04-02 | NCT06342336 | |
| Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Solid Tumor | Advanced Solid Tumor | Not yet recruiting | Early phase 1 | 2022-09-14 | NCT05539768 | |
| Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Early phase 1 | 2022-08-18 | NCT05505812 |